BioScrip, Inc. (BIOS) Earnings Report Preview For Friday's Release
BioScrip (NASDAQ:BIOS) is expected to report last fiscal quarter's results before the opening bell on March 09, 2012. Let's review how BioScrip has performed in recent quarters.
Who They Are:
BioScrip, Inc. provides pharmacy and home health services in the United States. It operates in two segments, Infusion/Home Health Services and Pharmacy Services. The company was founded in 1993 and is based in Elmsford, New York. BioScrip shares trade an average of 254,000 shares per day and has a marketcap of $378 Million.
Book Value: $3.78
Float Short: 4.14%
What To Expect:
The reporting quarter's estimated mean earnings are $0.09 per share .
Here is a look at the fiscal year revenue for BioScrip. 
Recent Stock and Valuation Performance:
The P/E ratio has been under pressure, as the current trailing twelve months P/E ratio is 17.3, while the forward P/E ratio is now 11.51.
Looking at the price movement over the last month, the stock has fallen in price -3.30%, with a one year change of 51.05%.
It is clear to see the stock is performing much better than the overall market with a relative double digit gain. When comparing to the S&P 500, the year to date difference is 10.59%.
Management has provided an improvement of year-over-year revenue. Revenue reported was $1.64 billion for 2010 vs. $1.33 billion for 2009. The bottom line has falling earnings year-over-year of $-69.14 million for 2010 vs. $54.10 million for 2009.The company's earnings before interest and taxes are rising with an EBIT year-over-year of $15.79 million for 2010 vs. $15.47 million for 2009.
Paid2Trade uses information believed to be correct, but is not guaranteed and is not independently checked for accuracy You may wish to use this article as a starting point of your own research with your financial planner.
